Roivant Sciences ROIV Stock
11.01 USD
{{ price }}
0.090911%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
7.86B USD
LOW - HIGH [24H]
10.88
-
11.18 USD
VOLUME [24H]
8.02M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1 USD
Roivant Sciences Price Chart
Roivant Sciences ROIV Financial and Trading Overview
| Roivant Sciences stock price | 11.01 USD |
| Previous Close | 9.71 USD |
| Open | 9.63 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1400 |
| Day's Range | 9.53 - 9.93 USD |
| 52 Week Range | 2.87 - 10.12 USD |
| Volume | 1.71M USD |
| Avg. Volume | 3.23M USD |
| Market Cap | 7.52B USD |
| Beta (5Y Monthly) | 1.217524 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.56 USD |
ROIV Valuation Measures
| Enterprise Value | 7.03B USD |
| Trailing P/E | N/A |
| Forward P/E | -7.4586463 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 174.4521 |
| Price/Book (mrq) | 7.543726 |
| Enterprise Value/Revenue | 163.026 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Roivant Sciences Stock Price History
| Beta (5Y Monthly) | 1.217524 |
| 52-Week Change | 126.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.12 USD |
| 52 Week Low | 2.87 USD |
| 50-Day Moving Average | 8.86 USD |
| 200-Day Moving Average | 6.98 USD |
ROIV Share Statistics
| Avg. Volume (3 month) | 3.23M USD |
| Avg. Daily Volume (10-Days) | 3.14M USD |
| Shares Outstanding | 758.43M |
| Float | 207.81M |
| Short Ratio | 5.23 |
| % Held by Insiders | 34.87% |
| % Held by Institutions | 53.39% |
| Shares Short | 14.16M |
| Short % of Float | 8.79% |
| Short % of Shares Outstanding | 1.87% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2517.65% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -27.13% |
| Return on Equity (ttm) | -72.81% |
Income Statement
| Revenue (ttm) | 43.13M USD |
| Revenue Per Share (ttm) | 0.06 USD |
| Quarterly Revenue Growth (yoy) | -29.89% |
| Gross Profit (ttm) | -413815000 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1245474944 USD |
| Diluted EPS (ttm) | -1.83 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.53B USD |
| Total Cash Per Share (mrq) | 2.01 USD |
| Total Debt (mrq) | 479.64M USD |
| Total Debt/Equity (mrq) | 33.61 USD |
| Current Ratio (mrq) | 6.74 |
| Book Value Per Share (mrq) | 1.315 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -811774016 USD |
| Levered Free Cash Flow (ttm) | -571135616 USD |
Profile of Roivant Sciences
| Country | United States |
| State | N/A |
| City | London |
| Address | 50 Broadway |
| ZIP | SW1H 0DB |
| Phone | 44 20 7400 3347 |
| Website | https://roivant.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 863 |
Roivant Sciences Ltd. focuses on discovery, development, and commercialization of medicines. It develops transformative medicines by building technologies and developing talent in creative ways, leveraging its platform to launch Vants nimble and focuses biopharmaceutical and health technology companies. The company was founded in 2014 and is based in London, the United Kingdom.
Q&A For Roivant Sciences Stock
What is a current ROIV stock price?
Roivant Sciences ROIV stock price today per share is 11.01 USD.
How to purchase Roivant Sciences stock?
You can buy ROIV shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Roivant Sciences?
The stock symbol or ticker of Roivant Sciences is ROIV.
Which industry does the Roivant Sciences company belong to?
The Roivant Sciences industry is Biotechnology.
How many shares does Roivant Sciences have in circulation?
The max supply of Roivant Sciences shares is 713.55M.
What is Roivant Sciences Price to Earnings Ratio (PE Ratio)?
Roivant Sciences PE Ratio is now.
What was Roivant Sciences earnings per share over the trailing 12 months (TTM)?
Roivant Sciences EPS is -1 USD over the trailing 12 months.
Which sector does the Roivant Sciences company belong to?
The Roivant Sciences sector is Healthcare.
Roivant Sciences ROIV included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Biotechnology NBI | 4131.38 USD — |
-1.41
|
— — | 4109.33 USD — | 4165.2 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2065.14 USD — |
-0.04
|
— — | 2039.56 USD — | 2065.23 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1839.71 USD — |
-3.16
|
— — | 1825.54 USD — | 1881.06 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4148.65 USD — |
+0.54
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
| Nasdaq US Smart Pharmaceuticals NQSSPH | 1337.85 USD — |
+0.58
|
— — | 1310.31 USD — | 1340.24 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2752.75 USD — |
+0.32
|
— — | 2724.48 USD — | 2752.94 USD — | — - | — — |
- {{ link.label }} {{link}}